Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
ORTHOPEDIATRICS CORP (KIDS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 Schlotterback Terry D (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Sold 2,610 shares @ $38.25, valued at $99.8k
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 4 Schlotterback Terry D (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Paid exercise price by delivering 529 shares @ $39.6865, valued at $21k
Exercised 670 options to buy @ $30.97, valued at $20.7k
08/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "02 03 04 05 42 0 2 3"
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/19/2023 3 Dyer George Sinclair Mitchell (Director) has filed a Form 3 on ORTHOPEDIATRICS CORP
05/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "02 03 04 05 42 0 2 3"
05/01/2023 8-K Quarterly results
Docs: "OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance"
05/01/2023 8-K Director compensation was amended/approved
Docs: "LIST OF EXHIBITS AND SCHEDULES Exhibits to Membership Interest Purchase Agreement Exhibit A – Stock Power Exhibit B – Membership Interest Assignment Agreement Exhibit C – Sellers’ Release Exhibit D – Form of Resignation Exhibit E – Unger Employment Agreement Schedules to Membership Interest Purchase Agreement Purchaser’ s Schedules Schedule 1.6 Resigning Managers/Officers Schedule 4.3 Purchaser Required Consents Schedule 6.7 Purchase Price Allocation Methodology Seller’ s Schedules Schedule 2.1 Membership Interest Schedule 2.4 Outstanding Options/Payments based on profitability Schedule 2.7 Accrued Liabilities Schedule 2.9 Compliance with Laws; Permits Schedule 2.10 Litigation Schedule 2.12 Tax Exceptions Schedule 2.14 Intellectual Property Schedule 2.15 Material Contracts Schedule 2.16 In...",
"OrthoPediatrics Corp. Non-Employee Director Compensation Policy, effective January 1, 2023"
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2023 4 Gerritzen Daniel J (General Counsel and Secretary) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Granted 19,617 shares @ $0
03/15/2023 4 Hauser Joseph W (Pres. Trauma & Def. Correction) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Granted 19,617 shares @ $0
03/15/2023 4 Odle Gregory A (President of Scoliosis) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Granted 19,617 shares @ $0
03/15/2023 4 Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Granted 12,266 shares @ $0
03/15/2023 4 Hite Fred (COO and CFO) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Granted 30,000 shares @ $0
03/15/2023 4 Bailey David R (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Granted 44,444 shares @ $0
03/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "02 03 04 05 42 0 2 3"
03/07/2023 4 Bailey David R (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Sold 4,052 shares @ $44.4004, valued at $179.9k
03/07/2023 4 Hite Fred (COO and CFO) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Sold 4,099 shares @ $43.766, valued at $179.4k
03/07/2023 4 Odle Gregory A (Executive Vice President) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Sold 3,421 shares @ $44.0276, valued at $150.6k
03/07/2023 4 Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Sold 4,515 shares @ $43.8254, valued at $197.9k
03/07/2023 4 Gerritzen Daniel J (General Counsel and Secretary) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Sold 3,315 shares @ $44.6203, valued at $147.9k
03/06/2023 4 Hauser Joseph W (Sr VP & GM Trauma & Deformity) has filed a Form 4 on ORTHOPEDIATRICS CORP
Txns: Sold 2,554 shares @ $43.7372, valued at $111.7k
03/01/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Quarterly results
Docs: "OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A BROWN ADVISORY INC reports a 6.9% stake in OrthoPediatrics Corp.
02/08/2023 SC 13G/A RIVERBRIDGE PARTNERS LLC reports a 4.6% stake in OrthoPediatrics Corp
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy